eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2023
vol. 17
 
Share:
Share:
DISEASES AND PROBLEMS DISTINGUISHED BY WHO AND FAO
abstract:
Original paper

PREVALENCE AND OUTCOMES OF DIABETES AMONG COVID-19 PATIENTS IN DUHOK COVID-19 HEALTH FACILITIES: A CROSS-SECTIONAL STUDY

Hozan Qasim Hussein
1
,
Ahmed Mohamed Salih
2
,
Muayad Aghali Merza
3

  1. Department of Medical Laboratory Sciences, College of Health Sciences, University of Duhok, Duhok, Kurdistan Region, Iraq
  2. Duhok Medical Research Center, College of Medicine, University of Duhok, Duhok, Kurdistan Region, Iraq
  3. Department of Clinical Pharmacology, College of Pharmacy, University of Duhok, Duhok, Kurdistan Region, Iraq
Health Prob Civil. 2023; 17(1): 24-35
Online publish date: 2022/12/24
View full text Get citation
 
PlumX metrics:
Background
The objectives of this study were to determine the prevalence of type 2 diabetes mellitus (T2DM) among patients with COVID-19, examining the relationship between COVID-19 severity and T2DM in hospitalized patients, detecting T2DM outcomes in COVID-19 patients, and identifying the vaccination rates of COVID-19 patients with T2DM.

Material and methods
A prospective, cross-sectional study was conducted on Duhok (Iraqi Kurdistan) hospitalized COVID-19 patients. Demographic, clinical, and laboratory characteristics of all confirmed COVID-19 by RT-PCR with coexisting T2DM were collected between early November 2021 and late April 2022. T2DM patients with HbA1c levels ≥7% were considered a poor control group, while those <7% were considered a good control group.

Results
Out of 530 hospitalized COVID-19 patients, 158 (29.81%) were T2DM. Among 158 patients, 23 (14.56%) were vaccinated, of whom 17 (10.76%) were fully vaccinated and 6 (3.80%) partially vaccinated. Considering patient outcomes, chronic pulmonary disease (p=0.0106), obesity (p=<0.0001), patients on combined oral antidiabetic and insulin (p=0.0204), and poorly controlled DM (p=<0.0001) were significant predictors of mortality.

Conclusions
The prevalence of T2DM in hospitalized COVID-19 patients was relatively high in Duhok. In contrast with the previous studies reported in the literature, the COVID-19 vaccination coverage was unsatisfactory. Therefore, raising awareness concerning health education about the severity and mortality rates of COVID-19 should be mandatory to achieve better disease prognosis.

keywords:

type II diabetes mellitus, outcomes, COVID-19, vaccine, prevalence, mortality


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.